Age-related macular degeneration (AMD), a progressive eye disease affecting close to 20 million Americans, is the leading cause of vision loss in people over 50. While existing treatments help many patients, others experience vision loss or even blindness. New therapies and improvements in the current standard of care aim to prevent disease progression and vision loss.
AMD affects the macula, an area in the back of the eye responsible for sharp vision. AMD symptoms include distorted vision, central vision loss (“blind spots”), or difficulty seeing in low light.